About Regional Cancer Care Associates
"Fight cancer in the way that's best for you at Regional Cancer Care Associates of Sparta, NJ."
Clinical Trials at Regional Cancer Care Associates
During the past decade, Regional Cancer Care Associates conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Regional Cancer Care Associates" #1 sponsor was "Amgen" with 2 trials, followed by "Dompé Farmaceutici S.p.A" with 1 trials
sponsored, "Eleison Pharmaceuticals LLC." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Odonate Therapeutics, Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Cancer Care Associates"
#1 collaborator was "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Regional Cancer Care Associates
According to Clinical.Site data, the most researched conditions in "Regional Cancer Care Associates" are
"Chemotherapy-induced Thrombocytopenia" (2 trials), "Breast Cancer" (1 trials), "Gastric Adenocarcinoma" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Metastatic Pancreatic Adenocarcinoma" (1 trials). Many other conditions were trialed in "Regional Cancer Care Associates" in a lesser frequency.
Clinical Trials Intervention Types at Regional Cancer Care Associates
Most popular intervention types in "Regional Cancer Care Associates" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Romiplostim" (2 trials), "5-fluorouracil" (1 trials), "Andecaliximab" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Regional Cancer Care Associates
The vast majority of trials in "Regional Cancer Care Associates" are
5 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Regional Cancer Care Associates
Currently, there are NaN active trials in "Regional Cancer Care Associates".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Regional Cancer Care Associates,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Regional Cancer Care Associates, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".